Cartilage re-growth ‘proven’ in clinical trial

SIGNIFICANT: Over half of joints see improvements. Photo credit: Twitter

THE REGENERATIVE CLINIC has welcomed the publication of new data revealing striking evidence of human tissue re-growth through the new non-surgical method of intra-articular fat injection.

In two studies the efficiency of both cartilage re-growth and pain reduction has been documented.

The first study was carried out on 17 patients (and 32 knees) with an average age of 69 with osteoarthritis classified as grade 3-4 (arthritis is graded 1 – 4 with 4 representing the most advanced cases with little remaining cartilage and often bone-on-bone symptoms).

Following the treatment patients were tested at 3, 6 and 12 months using a number of indicators including MRI scans and measurement of synovial fluid. In almost all cases there was an improvement seen, with more than half, 53.57 per cent of joints recorded seeing an increase in cartilage re-growth of +15% or more.

Professor Adrian Wilson of The Regenerative Clinic is a leading global expert in orthopaedic surgery based in the UK. He says; “This is a significant moment in charting the results of this treatment. I have seen the remarkable potential of this therapy first hand but it is crucial that we are able to quantify its success. These results are extremely encouraging and offer people experiencing pain and trauma in their joints a safe and effective alternative to traditional surgery. There is an explosion of clinical studies in this field and it is very exciting to be at the forefront of this new technology in the UK.”

The treatment induces host chondrocytes to make rejuvenating structural and biochemical changes in the cartilage. It was also noted that it was not just the thickness but rather the quality of the re-grown cartilage which was remarkable. Significant pain reduction was also noted across all patients after 3, 6 and 12 months.

© No part of this web site may be reproduced without written permission from the publishers. All rights reserved. Todos los derechos reservados.


Please enter your comment!
Please enter your name here

We welcome comments from readers on our website and across our social networks. We invite you to discuss issues and share your views and we encourage robust debate and criticism provided it is civil.

However we reserve the right to reject or edit comments that:

• Contain offensive language
• Include personal attacks of any kind
• Are likely to offend or target any ethnic, racial, nationality or religious group
• Are homophobic, transphobic, sexist, offensive or obscene
• Contain spam or include links to other sites
• Are clearly off topic
• Impersonate an individual or organisation, are fraudulent, defamatory of any person, threatening or invasive of another’s privacy or otherwise illegal
• Are trolling or threatening
• Promote, advertise or solicit the sale of any goods or services

You grant us a non-exclusive, royalty-free, perpetual, worldwide licence to republish any material you submit to us, without limitation, in any format.